Reach Us +44-1647-403003
Aims and Scope - Oncology and Cancer Case Reports
ISSN: 2471-8556

Oncology & Cancer Case Reports
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Aims and Scope

 » Immunological Disorders & Immunotherapy, is a broad-based journal was founded on two key tenets: To publish the most exciting researches on Immunological Disorders. Second to provide a rapid turn-around time possible for reviewing and publishing of articles freely for research, teaching and reference purposes.

All works published by OMICS Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adopt the work, provided the original work and source is appropriately cited. Immunological Disorders & Immunotherapy strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. Immunological Disorders & Immunotherapy updates the latest advancements in the field of Immunological Disorders & Immunotherapy. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Immunological Disorders & Immunotherapy are freely available to everyone immediately after publication. Immunological Disorders & Immunotherapy supports the Bethesda Statement on Open Access Publishing.